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Summary. Fibroblast growth factor 2 (FGF-2, basic 
fibroblast growth factor) has been reported to be 
elevated in tissues from benign prostatic hyperplasia 
(BPH), the most frequent neoplastic disease in aging 
men. This suggests that FGF-2 may play a significant 
role in the development of BPH. In this study the 
cellular distribution pattern of FGF-2 in tissues from 
BPH has been investigated by immunohistochemical and 
molecular biological methods. Radioimmunoassay 
revealed high concentrations of FGF-2, ranging between 
450 and 950 ng per g tissue. Immunoblots confirmed the 
presence of a 18 kDa FGF-2 in tissue extracts. By 
immunohistochemistry done with a polyclonal antibody 
to recombinant FGF-2 on paraffin sections, FGF-2 was 
localized in fibroblasts, endothelial cells and smooth 
muscle cells of tissue samples of BPH. Nuclei of these 
cells were labelled distinctly. Moreover the cytoplasm of 
smooth muscle cells was labelled moderately. No 
immunostaining was seen in prostatic epithelium. Non- 
radioactive in situ hybridization with digoxygenin- 
labelled oligonucleotides revealed the presence of 
mRNA for FGF-2 in smooth muscle cells of the prostatic 
stroma. These results provide evidence that FGF-2 may 
be produced locally in the human prostate as a stroma- 
specific mitogen and may play a causal role in the 
development of BPH. 
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Introduction 
Benign prostatic hyperplasia (BPH) is regarded as 
the most commonly occurring neoplastic disease in the 
aging human male (Isaacs and Coffey, 1989). Etiology 
and pathogenesis of this disease are stil l  poorly 
understood. Although there are a number of hypotheses 
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on the etiology of BPH (Isaacs and Coffey, 1989; 
Aumiiller, 1992) none of them has been fully proven. 
The role of androgens in the pathogenesis of BPH has 
been intensely studied (Griffiths et al., 1991; Sinowatz et 
al., 1995). Dihydrotestosterone (DHT) is the active 
intracellular androgen formed from testosterone by 5a -  
reductase. The concentration of DHT appears to be more 
increased in BPH tissue than in normal prostatic tissue 
(Griffiths et al., 1991), and there is no doubt that the 
DHT-receptor complex modulates gene expression. 
Current studies suggest that DHT is essential but not 
sufficient for proliferation in BPH, and that other 
regulatory factors, including peptid growth factors 
(Byrne et al., 1996; Culig et al., 1996; Cussenot et al., 
1997; De Bellis et al., 1998) are a prerequisite. 
The presence and possible function of various 
growth factors and their receptors in the normal and 
diseased human prostate have been reported in recent 
studies. Epidermal growth factor (EGF) (Sciarra et al., 
1995; Di Silverio et al., 1998) epidermal growth factor- 
related peptides, fibroblast growth factors (FGFs) 
(Mydlo et al., 1988; Sherwood et al., 1992; Begun et al., 
1995; Story, 1995; Schmitt et al., 1996) as well as their 
mRNAs (Mori et al., 1990) have been demonstrated in 
intact and diseased human prostate, but their role in 
prostatic growth is not fully understood. Stimulation of 
both prostatic stromal and epithelia1 cells by FGF-2 
(Mydlo et al., 1988; Luo et al., 1996) has been described 
and it was postulated that an imbalance in growth factor 
concentration may contribute to BPH. To date, little 
information is available on the cellular localization of 
growth factors in BPH. In this study we examined the 
cellular distribution pattern of FGF-2 and its mRNA 
using immunocytochemical and molecular biological 
methods. 
Material and methods 
Tissue samples 
Tissue samples of BPH (18 cases) were obtained at 
open prostatectomy. Small pieces of tissue (1 cm3) were 






